Merck & Co., Inc. (MRK) /

The cash flow of Merck & Co., Inc. over the past 10 years

Chart Merck & Co., Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →

In fiscal 2025, the latest fiscal year on file, Merck & Co., Inc.'s operating cash flow was $16.47B and its capital expenditures $4.11B, leaving free cash flow of $12.36B. Free cash flow was above zero in all 10 years shown. It ranged from $3.19B in fiscal 2020 to $18.1B in fiscal 2024. Capital expenditures were highest in fiscal 2021, at $4.45B.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2025ended Dec 31, 2025$16.47B$4.11B$12.36B
2024ended Dec 31, 2024$21.47B$3.37B$18.1B
2023ended Dec 31, 2023$13.01B$3.86B$9.14B
2022ended Dec 31, 2022$19.09B$4.39B$14.71B
2021ended Dec 31, 2021$13.12B$4.45B$8.67B
2020ended Dec 31, 2020$7.62B$4.43B$3.19B
2019ended Dec 31, 2019$8.88B$3.37B$5.51B
2018ended Dec 31, 2018$10.92B$2.62B$8.31B
2017ended Dec 31, 2017$6.45B$1.89B$4.56B
2016ended Dec 31, 2016$10.38B$1.61B$8.76B

Fiscal years as Merck & Co., Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on Merck & Co., Inc.

Companies of a similar size

Not investment advice. This page shows what Merck & Co., Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.